---
figid: PMC7350257__ijms-21-04507-g004
figtitle: PI3K-AKT-mTOR and WNT signaling crosstalk
organisms:
- NA
pmcid: PMC7350257
filename: ijms-21-04507-g004.jpg
figlink: pmc/articles/PMC7350257/figure/ijms-21-04507-f004/
number: F4
caption: PI3K-AKT-mTOR and WNT signaling crosstalk. Upon ligand binding (WNT ON),
  the destruction complex is recruited to the plasma membrane leading to β-catenin
  accumulation in both the cytoplasm and nucleus, where it activates gene expression
  through TCF binding. Insert illustrates WNT signaling in the absence of WNT ligand
  (WNT OFF). The interplay between PI3K-AKT-mTOR and WNT may occur through shared
  pathway components (e.g., GSK3β, PTEN, PP2A) and/or the joint regulation of transcription
  factors such as MYC, FOXO3a, SOX4 or YAP/TAZ. CDK4, cyclin-dependent kinase 4; LATS1/2,
  l-type amino acid transporter 1/2; LDHA, l-lactate dehydrogenase A chain; SLC2A3,
  solute carrier family 2, facilitated glucose transporter member 3 (encoding GLUT3,
  glucose transporter 3); TAZ, transcriptional co-activator with PDZ-binding motif;
  TEAD, transcriptional enhanced associate domain transcription factor; YAP, Yes-associated
  protein.
papertitle: 'The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR,
  MAPK, and WNT Signaling.'
reftext: Boris Y. Shorning, et al. Int J Mol Sci. 2020 Jun;21(12):4507.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9604229
figid_alias: PMC7350257__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7350257__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7350257__ijms-21-04507-g004.html
  '@type': Dataset
  description: PI3K-AKT-mTOR and WNT signaling crosstalk. Upon ligand binding (WNT
    ON), the destruction complex is recruited to the plasma membrane leading to β-catenin
    accumulation in both the cytoplasm and nucleus, where it activates gene expression
    through TCF binding. Insert illustrates WNT signaling in the absence of WNT ligand
    (WNT OFF). The interplay between PI3K-AKT-mTOR and WNT may occur through shared
    pathway components (e.g., GSK3β, PTEN, PP2A) and/or the joint regulation of transcription
    factors such as MYC, FOXO3a, SOX4 or YAP/TAZ. CDK4, cyclin-dependent kinase 4;
    LATS1/2, l-type amino acid transporter 1/2; LDHA, l-lactate dehydrogenase A chain;
    SLC2A3, solute carrier family 2, facilitated glucose transporter member 3 (encoding
    GLUT3, glucose transporter 3); TAZ, transcriptional co-activator with PDZ-binding
    motif; TEAD, transcriptional enhanced associate domain transcription factor; YAP,
    Yes-associated protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP6
  - LRP5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - AXIN1
  - AXIN2
  - TSC2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3B
  - APC
  - PROC
  - PTPA
  - CTNNB1
  - TAFAZZIN
  - WWTR1
  - YAP1
  - PTEN
  - MTOR
  - RPTOR
  - TTI1
  - DEPTOR
  - AKT1S1
  - HNF4A
  - RPS6KB1
  - LATS2
  - LATS1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - STK11
  - YWHAQ
  - MYC
  - EIF4EBP1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - SOX4
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - EGFR
  - AR
  - LDHA
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDK4
  - CDH1
  - FZR1
  - Amino acids
  - Ser
---
